Streetbeat News

Legal Regulatory

TMDX

Rosen Law Firm is pursuing a securities class action against TransMedics Group, Inc. (TMDX) for allegedly making false and misleading statements between February 28, 2023, and January 10, 2025. The lawsuit claims the company used kickbacks, fraudulent overbilling, and engaged in unsafe practices while hiding safety issues.

Portfolio Pulse from

March 27, 2025 | 12:15 am

APP

AppLovin Corporation (APP) is facing a class action lawsuit alleging fraudulent practices in digital advertising. Research firms Fuzzy Panda and Culper Research claim the company artificially inflated ad click-through and app download rates by exploiting Meta Platforms' advertising data. The stock price dropped 12% following these allegations, from $377.06 to $331.00 per share.

Portfolio Pulse from

March 27, 2025 | 12:15 am

BMWYY

President Trump signed an executive order imposing 25% tariffs on automobile and auto parts imports, effective April 2nd. The move aims to protect the U.S. industrial base, address a $93.5 billion annual auto parts trade deficit, and stimulate domestic manufacturing jobs. The tariffs are expected to generate over $100 billion in annual tariff revenue and potentially create construction and manufacturing jobs.

Portfolio Pulse from

March 27, 2025 | 12:00 am

PPTA

Rosen Law Firm has filed a class action lawsuit against Perpetua Resources Corp. (PPTA) alleging that the company misled investors about the true cost of the Stibnite Gold Project during the period of April 17, 2024 to February 13, 2025. The lawsuit claims that defendants did not accurately disclose the impact of inflation and undisclosed decisions that significantly increased projected initial capital expenses.

Portfolio Pulse from

March 26, 2025 | 11:45 pm

TFII

Law firm Levi & Korsinsky has filed a class action securities lawsuit against TFI International Inc. (TFII) alleging securities fraud between April 26, 2024 and February 19, 2025. The lawsuit claims the company made false statements about business performance, including losing small and medium business customers, declining TForce revenue, and cost management difficulties.

Portfolio Pulse from

March 26, 2025 | 11:45 pm

TFII

A class action lawsuit has been filed against TFI International Inc. (TFII) alleging securities fraud between April 26, 2024, and February 19, 2025. The lawsuit claims the company made false statements about its business performance, including losing small and medium business customers, declining TForce revenue, cost management difficulties, and declining profitability in its largest business segment.

Portfolio Pulse from

March 26, 2025 | 11:45 pm

PPTA

Rosen Law Firm has filed a class action lawsuit against Perpetua Resources Corp. (PPTA) alleging that the company misled investors about the true cost of the Stibnite Gold Project during the period of April 17, 2024 to February 13, 2025. The lawsuit claims that defendants did not accurately disclose the impact of inflation and undisclosed decisions that significantly increased projected initial capital expenses.

Portfolio Pulse from

March 26, 2025 | 11:45 pm

GSK

Levi & Korsinsky law firm has filed a securities class action lawsuit against GSK plc, alleging securities fraud between February 2020 and August 2022. The lawsuit claims GSK misled investors about the Zantac drug's potential cancer risks and the source of NDMA, suggesting the company knew about potential issues for nearly 40 years before withdrawing the drug from the market.

Portfolio Pulse from

March 26, 2025 | 11:30 pm

UCTT

A class action securities lawsuit has been filed against Ultra Clean Holdings, Inc. (UCTT) alleging securities fraud between May 6, 2024, and February 24, 2025. The lawsuit claims the company provided overly positive statements about demand in the Chinese market while concealing material adverse facts. On February 24, 2025, UCTT revealed 'demand softness' in China, causing its stock price to drop over 28% in a single day.

Portfolio Pulse from

March 26, 2025 | 11:30 pm

SANA

Law firm Levi & Korsinsky has filed a securities class action lawsuit against Sana Biotechnology, alleging the company made false statements about its financial capacity, product candidates, and operational sustainability between March 2023 and November 2024.

Portfolio Pulse from

March 26, 2025 | 11:30 pm